SWITCHING FROM ORIGINATOR ADALIMUMAB (HUMIRA®) TO BIOSIMILAR (HULIO®) IN AN IBD POPULATION

Martina Sciberras  1     Trevor Tabone  1     Abigail Mula  1     Stephanie Farrugia  1     Pierre Ellul  1    
1 Mater Dei Hospital, Msida, Malta

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing